251 related articles for article (PubMed ID: 15386590)
1. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.
Fairweather D; Frisancho-Kiss S; Rose NR
Rev Med Virol; 2005; 15(1):17-27. PubMed ID: 15386590
[TBL] [Abstract][Full Text] [Related]
2. From infection to autoimmunity.
Fairweather D; Kaya Z; Shellam GR; Lawson CM; Rose NR
J Autoimmun; 2001 May; 16(3):175-86. PubMed ID: 11334481
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
4. The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity.
Richer MJ; Horwitz MS
J Innate Immun; 2009; 1(5):421-34. PubMed ID: 20375600
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
Huber SA; Lyden DC; Lodge PA
Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of myocarditis and dilated cardiomyopathy.
Cihakova D; Rose NR
Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis.
Richer MJ; Fang D; Shanina I; Horwitz MS
Clin Immunol; 2006 Dec; 121(3):339-49. PubMed ID: 16963319
[TBL] [Abstract][Full Text] [Related]
8. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
Qian Q; Xiong S; Xu W
Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
[TBL] [Abstract][Full Text] [Related]
9. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent.
Triantafilou K; Orthopoulos G; Vakakis E; Ahmed MA; Golenbock DT; Lepper PM; Triantafilou M
Cell Microbiol; 2005 Aug; 7(8):1117-26. PubMed ID: 16008579
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in coxsackievirus B3 induced myocarditis.
Huber SA
Autoimmunity; 2006 Feb; 39(1):55-61. PubMed ID: 16455582
[TBL] [Abstract][Full Text] [Related]
11. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
12. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
13. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
14. Adjuvants and autoimmunity.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
[TBL] [Abstract][Full Text] [Related]
15. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Yue Y; Xu W; Hu L; Jiang Z; Xiong S
Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
[TBL] [Abstract][Full Text] [Related]
16. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
Horwitz MS; Ilic A; Fine C; Sarvetnick N
J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
[TBL] [Abstract][Full Text] [Related]
19. Viral damage or 'molecular mimicry'-placing the blame in myocarditis.
Rose NR
Nat Med; 2000 Jun; 6(6):631-2. PubMed ID: 10835674
[No Abstract] [Full Text] [Related]
20. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection.
Fairweather D; Frisancho-Kiss S; Gatewood S; Njoku D; Steele R; Barrett M; Rose NR
Autoimmunity; 2004 Mar; 37(2):131-45. PubMed ID: 15293883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
